SCNI

#5254
Scinai Immunotherapeutics Ltd. American Depositary Shares
0.5550 USD
-7.50%
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
0.5550
0.5550
Range Annuel
0.5500
1.0499
Changement quotidien
-7.50%
Changement Mensuel
-25.00%
Evolution sur 6 mois
-26.61%
Changement Annuel
-26.61%
Clôture Précédente
0.6000
Open
0.5550
Bid
Ask
Low
0.5550
High
0.5550
Volume
1
Open full chart

Financials

Overview Relevé Statistics
Quarterly Annual
  • Market Capitalization 1.9249 M
  • Employee 45
  • Founded 2003
  • CEO N/A
  • Website www.scinai.com
  • Headquarter Israel
  • FIGI BBG007TGL1R2
  • Industry Biotechnologies
Total revenue
Net income
Total debt
Free cash flow
Cash & equivalents

Scinai Immunotherapeutics Ltd - American Depositary Shares

BiondVax Pharmaceuticals Ltd. is an Israeli biopharmaceutical company focused on developing and manufacturing immunotherapeutic products, primarily for the treatment of infectious diseases and autoimmune diseases. In collaboration with the Max Planck Institute for Multidisciplinary Sciences and the University Medical Center Göttingen, both in Germany, BiondVax develops nanosized antibody therapies for diseases such as COVID-19, asthma and psoriasis.

Nouvelles